COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives
- PMID: 34330072
- PMCID: PMC8302829
- DOI: 10.1016/j.dsx.2021.102231
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives
Abstract
Background and aim: This review aims to report the current status of COVID-19 among people with diabetes, newly diagnosed diabetes, diabetic ketoacidosis, and programmatic efforts including vaccinations.
Methods: We conducted a literature search using PubMed, Google, and Scopus until July 15, 2021.
Results: In Saudi Arabia, most studies have reported diabetes as one of the highly prevalent comorbidities among patients with COVID-19. Currently, there are limited studies from Saudi Arabia on the newly diagnosed diabetes and diabetic ketoacidosis caused by COVID-19. The Saudi ministry has taken several measures to control the impact of COVID-19 among people with diabetes, including comprehensive guidelines and prioritized vaccinations. During the COVID-19 pandemic, the use of telehealth services dramatically increased in diabetes clinics in Saudi Arabia.
Conclusions: Focused and evidence-based interventions are essential to control the impact of COVID-19 among people with diabetes.
Keywords: COVID-19; Diabetes mellitus; SARS-CoV-2; Saudi Arabia; Vaccination.
Copyright © 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
References
-
- Coronavirus (COVID-19) dashboard. World Health Organization; 2021. https://covid19.who.int/
-
- Global research on coronavirus disease (COVID-19) 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-r...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
